Delivery Order SPE2DB22D2006-SPE2DB25FV9WR
Award Date
4/9/25
Potential Completion Date
4/10/25
Potential Value
$33K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,839.90, is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used for the treatment of diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of April 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,570.74 firm fixed-price contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for diabetes management. The contract has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,827.58 Firm Fixed Price contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, which is a medication used for diabetes management. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,751.66, is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used in the treatment of diabetes. The contract has a firm fixed price and an ultimate completion date of October 22, 2024. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,447.36, is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used to treat type 2 diabetes. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,589.45 firm fixed price contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of February 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,819.97, is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for the treatment of diabetes. The contract has a firm fixed price pricing type and a period of performance through January 22, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used for diabetes management. The contract has a firm fixed price of $28,022.06 and a completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,994.71, is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,608.43 fixed-price contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used to treat diabetes. The contract has an ultimate completion date of December 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...